is a project merging science communication and technology development.

We describe any human characteristics – pathological and physiological – explained by changes in the genome. Currently the most important of them are: cancer diseases (eg. mutation in BRCA1 raising a risk of breast cancer), Mendelian diseases (eg. HTT gene in Huntington disease), behavior contributing to diseases (eg. mutations in KLB raising tendency for heavy-drinking), and also normal traits (eg. 13 genes defining a colour of hair). We distinguish news reporting that is brief (about biopharmaceuticals, therapies and new research) from explanatory, educational and informational articles that are more comprehensive and constantly up-to-date (about diseases, behaviour and traits).

We develop technology assisting scientific analysis. During the process of content preparation, fact-checking and updating, we derive many sets of methods which are implemented computationally. The main goal of the technology is handling massive information overload – in science specifically publication overload. Automatic analysis of publications, their context and their terminology have potential to create scientific equivalent of Twitter where every 280 characters are used for trustworthy summarisation of any research.

We are motivated by own struggle with information overload: difficulty to follow many new publications, to prepare extensive systematic reviews, to communicate science, to assist journalists and internet users. As Stanisław Lem predicted in Megabit Bomb during an advent of the internet, a pace of global content creation exceeded human capacity to read and understand, which led to filter bubbles, pseudoscientific movements, massive discrimination and many other phenomena. We want to disarm this megabit bomb by the newest IT inventions combined with knowledge of scientific and journalistic conduct. This website is hoped to be the first step.

The project is managed by Rafał Grochala (biology student & IT professional).
Feel free to contact at TT here.

Current phase of the project: Q2 prototype and experiments.